Aspirin And Extended - Release Dipyridamole Capsules, 25 Mg / 200 Mg Capsule
Product Images NDC 0904-7056

4 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aspirin And Extended - Release Dipyridamole Capsules, 25 Mg / 200 Mg (NDC 0904-7056). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dipyridamole (Aspirin Dypyridamole 1)

Dipyridamole (Aspirin Dypyridamole 1)
Chemical structure of the active ingredient Dipyridamole, showing its molecular formula C24H40N8O4 and molecular weight 504.63. The diagram depicts the arrangement of atoms and bonds in the Dipyridamole molecule.*
FDA Label Image

Aspirin (Aspirin Dypyridamole 2)

Aspirin (Aspirin Dypyridamole 2)
Chemical structure of aspirin, showing the molecular formula C9H8O4 and molecular weight 180.16. The diagram includes the aromatic benzene ring with attached acetate and carboxylic acid functional groups.*
FDA Label Image

Aspirin (Aspirin Dypyridamole 3)

Aspirin (Aspirin Dypyridamole 3)
A line chart depicting cumulative stroke rate (%) over 24 months of follow-up for three treatment groups: aspirin and extended-release dipyridamole, aspirin (ASA), and extended-release dipyridamole (ER-DP), compared to placebo. The chart shows stroke rates increasing over time, with separate lines for each treatment group labeled with distinct markers.*
FDA Label Image

25mg/200mg Carton Label (809b98fe Ec33 4380 9a17 99149afd4cb7 00)

25mg/200mg Carton Label (809b98fe Ec33 4380 9a17 99149afd4cb7 00)
Label for Aspirin and Extended-Release Dipyridamole Capsules, 25 mg / 200 mg, by Major Pharmaceuticals. The unit dose package contains 20 capsules (5 x 4). The label includes dosage strength, storage instructions, warnings, and barcodes. It specifies the product is Rx only and intended for institutional use, with manufacturing details noting production in India and packaging by Major Pharmaceuticals in Indianapolis, IN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.